Deutsche Krebshilfe e.V., Bonn

• NCT06019130

  Collaborator, Phase 2, Recruiting, 57 people, 31 Aug 2023

• Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer

  Collaborator, Phase 3, Terminated, 215 people, 31 Jul 2020

• NCT04447352

  Collaborator, Phase 3, Recruiting, 200 people, 25 Jun 2020

• NCT04375605

  Collaborator, Phase 3, Completed, 342 people, 5 May 2020

• NCT04043494

  Collaborator, Phase 3, Recruiting, 683 people, 2 Aug 2019

• NCT03643276

  Collaborator, Phase 3, Recruiting, 5,000 people, 22 Aug 2018

• NCT03206671

  Collaborator, Phase 3, Active, not recruiting, 650 people, 2 Jul 2017

• NCT03158389

  Collaborator, Phase 1/2, Completed, 228 people, 18 May 2017

• NCT02684708

  Collaborator, Phase 3, Completed, 2,921 people, 18 Feb 2016

• NCT02170090

  Collaborator, Phase 3, Active, not recruiting, 789 people, 23 Jun 2014

• NCT01126216

  Collaborator, Phase 3, Terminated, 221 people, 19 May 2010

• NCT01117441

  Collaborator, Phase 3, Completed, 6,136 people, 5 May 2010

• NCT01088750

  Collaborator, Phase 4, Completed, 225 people, 17 Mar 2010

• NCT00964977

  Collaborator, Phase 3, Completed, 209 people, 25 Aug 2009

• NCT00433459

  Collaborator, Phase 3, Completed, 2,134 people, 12 Feb 2007

• NCT00266136

  Collaborator, Phase 3, Completed, 3,500 people, 15 Dec 2005

• NCT00199069

  Collaborator, Phase 4, Completed, 720 people, 20 Sept 2005

• NCT00198991

  Collaborator, Phase 4, Completed, 1,883 people, 20 Sept 2005

• NCT00130858

  Collaborator, Phase 2, Completed, 90 people, 16 Aug 2005

• NCT00111345

  Collaborator, Phase 2/3, Status unknown, 550 people, 20 May 2005

Sources: clinicaltrials.gov

• Loss of the Y chromosome drives basal identity and metastatic potential via epigenetic reprogramming in pancreatic cancer

  DEFEAT-PDAC-P02, 7 Oct 2026

Sources: api.crossref.org